SynthesisAesthetic plastic surgery2026
What Happened to Masticatory Muscles after Botulinum-Toxin-Type A Injection into Masseter: A Systematic Review.
Synthesis in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBotulinum toxin type A (BoNT-A) is commonly used in neuromuscular disorders and cosmetic fields, but the detailed histological and subcellular changes in masticatory muscles, mainly in masseter, remain underexplored.
methodsThe literature review was conducted using the PubMed and Cochrane databases between January 2000 and September 2024. Studies of BoNT-A injection in masseters with available full- text and extractable data were included and were grouped depending on injected species. The sample size, dose of injection, follow-up duration, and detailed muscle changes were concluded.
resultsFourteen articles were eligible for reviewing, among which 2 were conducted on humans, and 12 were conducted on animals including rats (n=5), mice (n=2), rabbits (n=3) and pigs (n=2). Morphological analysis showed muscle atrophy with variable recovery. Histological findings included decreased fiber diameter, disrupted arrangements, and shifts in myosin-heavy-chain fiber types. Immunohistochemistry indicated increased cell proliferation and nuclear centralization. Electrophysiological assessments demonstrated reduced EMG amplitudes and shorter signal durations, correlating with muscle size and bite force. Ion analysis revealed increased sodium, chloride and sulfur, and decreased potassium and phosphorus.
conclusionBoNT-A injection causes dose-dependent denervation and dysfunction in masticatory muscles, with incomplete recovery over time. However, due to very limited human data, these findings should be interpreted cautiously, and strong clinical extrapolations are not justified. These findings provide valuable insights into the long-term effects of BoNT-A on muscle structure and function, highlighting the need for further research into the mechanisms underlying these changes and their clinical implications for both therapeutic and aesthetic applications. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
41214320What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.